| Literature DB >> 26109502 |
Céline Vetter1, Elizabeth E Devore2, Cody A Ramin3, Frank E Speizer4, Walter C Willett5, Eva S Schernhammer6.
Abstract
OBJECTIVE: To examine whether a mismatch between chronotype (i.e., preferred sleep timing) and work schedule is associated with type 2 diabetes risk. RESEARCH DESIGN AND METHODS: In the Nurses' Health Study 2, we followed 64,615 women from 2005 to 2011. Newly developed type 2 diabetes was the outcome measure (n = 1,452). A question on diurnal preference ascertained chronotype in 2009; rotating night shift work exposure was assessed regularly since 1989.Entities:
Mesh:
Year: 2015 PMID: 26109502 PMCID: PMC4542269 DOI: 10.2337/dc15-0302
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112
Age-adjusted characteristics of women in the NHS2 by chronotype in 2009
| Chronotype | |||
|---|---|---|---|
| Early
( | Intermediate
( | Late
( | |
| Age (years) | 54.3 (4.6) | 54.2 (4.6) | 54.2 (4.7) |
| Median annual family income ($) | 66,599 (24,714) | 65,767 (23,883) | 64,953 (23,393) |
| Family history of diabetes | 37 | 37 | 38 |
| BMI (kg/m2) | 26.4 (5.6) | 27.3 (6.1) | 28.6 (6.6) |
| Smoking status | |||
| Never | 67 | 67 | 64 |
| Past | 28 | 28 | 27 |
| Current 1–14 cigarettes/day | 3 | 3 | 5 |
| Current ≥15 cigarettes/day | 2 | 2 | 4 |
| Alcohol consumption 2007 (g/day) | 6.9 (10.4) | 6.6 (10.4) | 5.9 (10.5) |
| Physical activity (MET-h/week) | 28.2 (34.6) | 23.1 (27.6) | 19.8 (26.6) |
| Diet score (AHEI) | 56.8 (12) | 55.0 (12.1) | 53.4 (12.3) |
| Ever use of oral contraceptives | 88 | 88 | 87 |
| Postmenopausal | 66 | 66 | 67 |
| Ever use of postmenopausal hormones | 39 | 40 | 39 |
| Sleep duration in current work schedule | |||
| ≤5 h | 5 | 5 | 8 |
| 6 h | 20 | 21 | 25 |
| 7 h | 40 | 41 | 34 |
| 8 h | 32 | 29 | 26 |
| ≥9 h | 3 | 4 | 7 |
| Ever rotating night shift work | 70 | 70 | 73 |
| Cumulative night shift work exposure (years) | 3.3 (4.2) | 3.4 (4.4) | 4.2 (5.1) |
| Physician-diagnosed depression | 18 | 25 | 32 |
| Ever regular antidepressive medication use | 28 | 35 | 43 |
Data are mean (SD) or %.
1Value is not age adjusted.
2At census tract level.
3Weekly energy expenditure in MET-h from recreational and leisure-time activities.
4AHEI 2010 [Chiuve et al. (23)] in 2007 (arbitrary units 0–100).
5Restricted to women ever reporting rotating night shift work since 1989.
6Self-reported from 2003 onward.
7Self-reported; assessed in 1993, 1997, 2001, and 2003–2009.
Analysis of the association between chronotype and type 2 diabetes in the NHS2
| Chronotype | |||
|---|---|---|---|
| Intermediate | Early | Late | |
| Prevalence analysis: follow-up period 2005–2011 | |||
| Model 1 | 1.00 | 0.74 (0.66–0.83) | 1.39 (1.20–1.61) |
| Model 2 | 1.00 | 0.82 (0.73–0.93) | 1.17 (1.01–1.36) |
| Model 3 | 1.00 | 0.87 (0.77–0.98) | 1.04 (0.89–1.21) |
| Incidence analysis: follow-up period 2009–2011 | |||
| Model 1 | 1.00 | 0.77 (0.60–0.99) | 1.34 (0.98–1.84) |
| Model 2 | 1.00 | 0.88 (0.68–1.13) | 1.11 (0.81–1.53) |
| Model 3 | 1.00 | 0.93 (0.73–1.20) | 1.01 (0.73–1.38) |
Data are MVOR (95% CI) in the prevalence analysis (n = 64,615; 1,472 cases) and hazard ratio (95% CI) in the incidence analysis (n = 62,943; 319 cases).
1Age-adjusted model.
2Additionally adjusted for family history of diabetes (yes/no), smoking status (never, past, current 1–14 cigarettes/day, current ≥15 cigarettes/day), alcohol intake (0, 0.1–5, 5.1–10, 10.1–15, >15 g/day), physical activity (quintiles of MET-h/week), diet score (quintiles, AHEI as assessed in 2007), oral contraceptive use (ever, never), menopausal status (pre-, postmenopause), postmenopausal hormone use (premenopause, ever, never), sleep duration (<5, 6, 7, 8, >9 h as assessed in 2009), median annual household income ($, in tertiles), depressive symptoms (yes/no based on regular medication use or self-reported physician diagnosis), and cumulative rotating night shift work exposure since 1989 (<1, 1–10, ≥10 years).
3Additionally adjusted for BMI (<25, 25–30, 30–35, >35 kg/m2).
Risk for type 2 diabetes in the NHS2 by chronotype and stratified by cumulative rotating night shift work history
| Chronotype | |||
|---|---|---|---|
| Intermediate | Early | Late | |
| Prevalence analysis: follow-up period 2005–2011 | |||
| No rotating night shift work | 1.00
( | 0.81 (0.63–1.04)
( | 1.51 (1.13–2.03)
( |
| <10 years | 1.00
( | 0.84 (0.72–0.98)
( | 0.93 (0.76–1.13)
( |
| ≥10 years | 1.00
( | 1.15 (0.82–1.63)
( | 0.86 (0.56–1.33)
( |
| Incidence analysis: follow-up period 2009–2011 | |||
| No rotating night shift work | 1.00
( | 0.75 (0.44–1.29)
( | 1.43 (0.77–2.62)
( |
| <10 years | 1.00
( | 0.91 (0.67–1.25)
( | 0.86 (0.57–1.32)
( |
| ≥10 years | 1.00
( | 1.63 (0.79–3.34)
( | 1.01 (0.43–2.37)
( |
Data are MVOR (95% CI) in the prevalence analysis (n = 64,615; 1,472 cases) and hazard ratio (95% CI) in the incidence analysis (n = 62,943; 319 cases). The interaction between chronotype and cumulative shift work exposure is significant in both analyses. Models adjusted for age, family history of diabetes (yes/no), BMI (<25, 25–30, 30–35, >35 kg/m2), smoking status (never, past, current 1–14 cigarettes/day, current ≥15 cigarettes/day), alcohol intake (0, 0.1–5, 5.1–10, 10.1–15, >15 g/day), physical activity (quintiles of MET-h/week), diet score (quintiles, AHEI as assessed in 2007), oral contraceptive use (ever, never), menopausal status (pre-, postmenopause), postmenopausal hormone use (premenopause, ever, never), self-reported sleep duration (<5, 6, 7, 8, >9 h as assessed in 2009), median annual household income ($, in tertiles), and depressive symptoms (yes/no based on regular medication use or self-reported physician diagnosis).